Dialybrid S.r.l.
PrivateLast Round
Seed
Aug 4, 2020
Total Funding Raised
$350,000
Company Overview
Dialybrid S.r.l. is a medical device company that develops and commercializes novel arteriovenous vascular grafts for hemodialysis using its proprietary Silkothane® technology.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dialybrid S.r.l. Comparables
Compare Dialybrid S.r.l. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vascudyne | 81% | |
| Nicast | 78% | |
| Healionics Corporation | 78% | |
Dialybrid S.r.l. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 4, 2020 |
Dialybrid S.r.l. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LIFTT EuroInvest | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 4, 2020
$350K round led by LIFTT EuroInvest
Dialybrid S.r.l. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Dialybrid S.r.l.'s valuation, stock price, and market status.